Innovative Pharmaceutical Biotech's total assets for Q2 2024 were HK$1.38B, a decrease of -0.30% from the previous quarter. HK:0399 total liabilities were HK$907.62M for the fiscal quarter, a -14.66% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.